The Cross-Talk between Angiotensin and Insulin Differentially Affects Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Mediated Signaling in Rat Heart: Implications for Insulin Resistance

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5604-5614

  Carvalheira, José B C ^a   Calegari, Vivian C ^a   Zecchin, Henrique G ^a   Nadruz Jr , Wilson ^a   Guimarães, Regina B ^a   Ribeiro, Eliane B ^a   Franchini, Kleber G ^a   Velloso, Lício A ^a   Saad, Mario J A ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Cd Univ Zeferino Vaz ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; GROWTH FACTOR RECEPTOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; ISOPHANE INSULIN; JANUS KINASE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEART; IMMUNOPRECIPITATION; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; GRB2 ADAPTOR PROTEIN; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; JANUS KINASE 2; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; OBESITY; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RATS, ZUCKER; RECEPTOR CROSS-TALK; VASOCONSTRICTOR AGENTS;

EID: 0345257076     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0788     Document Type: Article

References (37)

1. Griendling KK, Lassegue B, Murphy TJ, Alexander RW 1994 Angiotensin II receptor pharmacology. Adv Pharmacol 28:269-306
2. Shirai H, Takahashi K, Katada T, Inagami T 1995 Mapping of G protein coupling sites of the angiotensin II type 1 receptor. Hypertension 25:726-730
3. Bernstein KE, Ali MS, Sayeski PP, Semeniuk D, Marrero MB 1998 New insights into the cellular signaling of seven transmembrane receptors: the role of tyrosine phosphorylation. Lab Invest 78:3-7
4. Sadoshima J 1998 Versatility of the angiotensin II type 1 receptor. Circ Res 82:1352-1355
5. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC 1995 Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 77:1053-1059
6. Sadoshima J, Izumo S 1996 The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kiriase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15:775-787
7. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T 1998 Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896
8. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC 2000 Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor β receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275:15926-15932
9. Marrero MB, Schieffer B, Paxton WG, Schieffer E, Bernstein KE 1995 Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem 270:15734-15738
10. Venema RC, Venema VJ, Eaton DC, Marrero MB 1998 Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J Biol Chem 273:30795-30800
11. Molkentin JD, Dorn II IG 2001 Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426
12. Saad MJ, Velloso LA, Carvalho CR 1995 Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J 310:741-744
13. White MF, Yenush L 1998 The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228:179-208
14. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
15. Folli F, Saad MJ, Backer JM, Kahn CR 1992 Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171-22177
16. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers Jr MJ, Backer JM, Ullrich A, White MF 1993 The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J 12:1929-1936
17. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME 1997 Akt phosphorylation of BAD couples survival signals to the cell: intrinsic death machinery. Cell 91:231-241
18. Datta SR, Brunet A, Greenberg ME 1999 Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
19. Romashkova JA, Makarov SS 1999 NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90
20. Kennedy SG, Kandel ES, Cross TK, Hay N 1999 Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 19:5800-5810
21. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98:1607-1612
22. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J 1993 The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955
23. Bueno OF, Molkentin JD 2002 Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776-781
24. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR 1996 Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93:12490-12495
25. Scott AM, Atwater I, Rojas E 1981 A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia 21:470-475
26. Ardaillou R 1999 Angiotensin II receptors. J Am Soc Nephrol 10(Suppl 11): S30-S39
27. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J 2002 AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277:9268-9277
28. Tari AM, Lopez-Berestein G 2001 GRB2: a pivotal protein in signal transduction. Semin Oncol 28:142-147
29. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP 1997 Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100:2158-2169
30. Folli F, Saad MJ, Velloso L, Hansen H, Carandente O, Feener EP, Kahn CR 1999 Crosstalk between Insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 107:133-139
31. Swynghedauw B 1999 Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262
32. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI 2002 Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106: 909-912
33. Clerk A, Sugden PH 1999 Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol 83: 64H-69H
34. Velloso LA, Carvalho CR, Rojas FA, Folli F, Saad MJ 1998 Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway. Cardiovasc Res 40:96-102
35. Jonassen AK, Sack MN, Mjos OD, Yellon DM 2001 Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191-1198
36. Bray GA 1977 The Zucker-fatty rat: a review. Fed Proc 36:148-153
37. Zhou YT, Graybum P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH 2000 lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784-1789